Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Investigational treatments for cytomegalovirus infection in phase I and II study.
Journal: Expert opinion on investigational drugs
Published: October 21, 2025
American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy Recipients.
Journal: Transplantation and cellular therapy
Published: June 19, 2025
Role of R5 pyocin in the predominance of high-risk Pseudomonas aeruginosa isolates.
Journal: Microbiological research
Published: April 03, 2025
Role of R5 Pyocin in the Predominance of High-Risk Pseudomonas aeruginosa Isolates.
Journal: bioRxiv : the preprint server for biology
Published: October 17, 2024
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin.
Journal: Antimicrobial agents and chemotherapy
Published: July 12, 2024
The impact of an intervention to reduce dispersal from wastewater drain sites on carbapenem-resistant Pseudomonas aeruginosa colonization and bloodstream infection on a hematopoietic cell transplant and hematologic malignancy unit.
Journal: Infection control and hospital epidemiology
Published: February 22, 2024
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin.
Journal: bioRxiv : the preprint server for biology
Published: February 14, 2024
Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia.
Journal: Antimicrobial agents and chemotherapy
Published: July 03, 2023
New Perspectives on Antimicrobial Agents: Isavuconazole.
Journal: Antimicrobial agents and chemotherapy
Published: August 15, 2022
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
Journal: Microbiology spectrum
Published: April 27, 2022
Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant Recipients.
Journal: Frontiers in cellular and infection microbiology
Published: March 25, 2022
Last Updated: 09/26/2026